We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$158M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$70.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$34.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.9M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$22.9M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QXO
3501
QXO Inc
QXO
$16.2B
$29.4K ﹤0.01%
410
+278
+211% +$34.1K
BCLI
3502
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$29.4K ﹤0.01%
5,772
+5,038
+686% +$37.8K
ARAY icon
3503
Accuray
ARAY
$33.3M
$29.3K ﹤0.01%
16,090
+14,082
+701% +$26.9K
TSHA icon
3504
Taysha Gene Therapies
TSHA
$2B
$29.2K ﹤0.01%
13,037
-11,092
-46% -$32.3K
WTM icon
3505
White Mountains Insurance
WTM
$5.06B
$29.1K ﹤0.01%
16
-134
-89% -$237K
INZY
3506
DELISTED
Inozyme Pharma
INZY
$29.1K ﹤0.01%
6,519
+6,121
+1,538% +$29.7K
CFFI icon
3507
C&F Financial
CFFI
$284M
$29.1K ﹤0.01%
603
+596
+8,514% +$26K
AMZU icon
3508
Direxion Daily AMZN Bull 2X ETF
AMZU
$323M
$29K ﹤0.01%
778
+84
+12% +$2.91K
BKSY icon
3509
BlackSky Technology
BKSY
$1.31B
$29K ﹤0.01%
3,389
+2,518
+289% +$23.6K
HCM icon
3510
HUTCHMED
HCM
$2.13B
$29K ﹤0.01%
1,694
-2,964
-64% -$54.7K
SLDB icon
3511
Solid Biosciences
SLDB
$967M
$29K ﹤0.01%
+5,114
New +$45.8K
SST icon
3512
System1
SST
$19.8M
$28.9K ﹤0.01%
1,904
+1,219
+178% +$20.6K
EWM icon
3513
iShares MSCI Malaysia ETF
EWM
$333M
$28.9K ﹤0.01%
1,287
-2,318
-64% -$52.2K
RPT
3514
Rithm Property Trust
RPT
$100M
$28.8K ﹤0.01%
1,346
+1,298
+2,704% +$27.7K
PAYS icon
3515
Paysign
PAYS
$711M
$28.8K ﹤0.01%
6,687
+6,111
+1,061% +$26.9K
SRTA
3516
Strata Critical Medical Inc
SRTA
$530M
$28.7K ﹤0.01%
8,234
+5,640
+217% +$18.8K
HNRG icon
3517
Hallador Energy
HNRG
$755M
$28.6K ﹤0.01%
3,684
+3,058
+488% +$19.2K
GDRX icon
3518
GoodRx Holdings
GDRX
$1.23B
$28.6K ﹤0.01%
3,669
-28,597
-89% -$212K
CMBM
3519
DELISTED
Cambium Networks
CMBM
$28.6K ﹤0.01%
10,255
+8,656
+541% +$30.4K
ME
3520
DELISTED
23andMe Holding Co
ME
$28.5K ﹤0.01%
3,649
+2,849
+356% +$27.3K
GRSD
3521
Grandstand Limited Ordinary Shares
GRSD
$67M
$28.5K ﹤0.01%
3,470
+2,266
+188% +$19.1K
HRTG icon
3522
Heritage Insurance Holdings
HRTG
$987M
$28.5K ﹤0.01%
4,028
+703
+21% +$6.21K
CKPT
3523
DELISTED
Checkpoint Therapeutics
CKPT
$28.5K ﹤0.01%
13,253
+6,027
+83% +$10.7K
LXRX icon
3524
Lexicon Pharmaceuticals
LXRX
$1.05B
$28.5K ﹤0.01%
16,952
-1,085
-6% -$1.95K
EVBN
3525
DELISTED
Evans Bancorp Inc
EVBN
$28.4K ﹤0.01%
1,012
+840
+488% +$22.6K
139 140
141
142 143

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.